Figure A (Faricimab 01)
Vabysmo Injection, Solution
Product Images NDC 50242-096
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vabysmo (NDC 50242-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Faricimab 02)
Figure C (Faricimab 03)
Figure D (Faricimab 04)
Figure E (Faricimab 05)
Figure F (Faricimab 06)
Figure G (Faricimab 07)
Figure H (Faricimab 08)
Figure I (Faricimab 09)
Figure J (Faricimab 10)
Figure K (Faricimab 11)
Figure L (Faricimab 12)
Figure 1 (Faricimab 13)
The text describes the mean change in BCVA (a visual acuity measurement) in ETDRS letters over a period of a few weeks in a study where one group received VABYSMO (458 individuals) and another received Afbercept (451 individuals). Unfortunately, no further information is available.*
Figure 2 (Faricimab 14)
Figure 3 (Faricimab 15)
Figure 4 (Faricimab 16)
Principal Display Panel (6 mg Vial Carton)
This text is a description of a medication for intravitreal injection. The medication is called "faricimab-svoa" and is contained in a single-dose vial. The vial contains 6mg of the medication, which is a 0.05mL solution of 120mg/mL. The package includes one single-dose vial and one transfer filter needle from Genentech. The user is advised to discard any unused portion. The National Drug Code (NDC) for the medication is 50242-096-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
